Evidence map›Paper›PMID 29670663›Full record

ArticleEvidence-based complementary and alternative medicine : eCAM2018

The Effect of Sanggua Drink Extract on Insulin Resistance through the PI3K/AKT Signaling Pathway.

Yu Cai, Ying Wang, Fei Zhi, Qi-Chang Xing, Yun-Zhong Chen

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Evidence-based complementary and alternative medicine : eCAM, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Effect of feedingVeterinary world · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Aloperine Relieves Type 2 Diabetes MellitusFrontiers in pharmacology · 2020
    Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Yu CaiCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.
Ying WangCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.
Fei ZhiCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.
Qi-Chang XingCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.
Yun-Zhong ChenCollege of Pharmacy, Hubei University of Chinese Medicine, Wuhan 430065, China.ORCID 0000-0001-5662-1621
Hubei University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treating type 2 diabetes mellitus (T2DM) using thiazolidinediones and biguanides can present several challenges for patients. Sanggua Drink (SGD) is a commonly used agent in traditional Chinese medicine, and it consists of

Indexed as

Insulin ResistanceAnimalsBeveragesBlood GlucoseDiabetes Mellitus, ExperimentalDiabetes Mellitus, Type 2DioscoreaDrugs, Chinese HerbalGlucose Transporter Type 4Hypoglycemic AgentsInsulinMomordicaMorusPhosphatidylinositol 3-KinasesPhytotherapyProto-Oncogene Proteins c-aktBlood GlucoseDrugs, Chinese HerbalGlucose Transporter Type 4Hypoglycemic AgentsInsulinPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Identifiers

PMID29670663
PMCPMC5836421
OpenAlexW2791046398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.